Corrigendum: Randomized, Double Blind, Placebo Controlled, Clinical Trial to Study Ashwagandha Administration in Participants Vaccinated Against COVID-19 on Safety, Immunogenicity, and Protection With COVID-19 Vaccine–A Study Protocol

Slični predmeti

• Corrigendum: Randomized, Double Blind, Placebo Controlled, Clinical Trial to Study Ashwagandha Administration in Participants Vaccinated Against COVID-19 on Safety, Immunogenicity, and Protection With COVID-19 Vaccine–A Study Protocol
  od: Arvind Chopra, i dr.
  Izdano: (2022-03-01)
• Ashwagandha (Withania somnifera) and Shunthi (Zingiber officinale) in mild and moderate COVID-19: An open-label randomized controlled exploratory trial
  od: Harbans Singh, i dr.
  Izdano: (2023-09-01)
• Ashwagandha under fire: A critical scientific analysis of regulatory decisions
  od: Jorge Luis Berra, i dr.
  Izdano: (2024-07-01)
• Ashwagandha jako adaptogen terapeutyczny: przegląd potencjalnych zastosowań klinicznych
  od: Hanna Gruchot, i dr.
  Izdano: (2026-06-01)
• Potential clinical usage of ashwagandha root extract: A review
  od: Zofia Potocka, i dr.
  Izdano: (2023-05-01)